The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

PURPOSE: The platelet-derived growth factor (PDGF) signalling pathway is often dysregulated in cancer and PDGF-receptor expression has been linked to unfavourable prognostic factors in breast cancer (e.g. ER negativity, high Ki67 and high grade). This study aimed to evaluate the expression of PDGFRα...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansson, Sara, Aaltonen, Kristina, Bendahl, Pär-Ola, Falck, Anna-Karin, Karlsson, Maria, Pietras, Kristian, Rydén, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945746/
https://www.ncbi.nlm.nih.gov/pubmed/29380207
http://dx.doi.org/10.1007/s10549-018-4664-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945746/
https://www.ncbi.nlm.nih.gov/pubmed/29380207
http://dx.doi.org/10.1007/s10549-018-4664-7

Ejemplares similares